Joint Pain Injections Market - by Injection type (Hyaluronic Acid Injections, Corticosteroid Injections, Platelet Rich Plasma Injections), By Joint type (Knee, Shoulder & Elbow, Ankle & Hip), By End-use (Hospitals, Clinics) & Global Forecast, 2023-2032
Published Date: August - 2024 | Publisher: MIR | No of Pages: 240 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationJoint Pain Injections Market - by Injection type (Hyaluronic Acid Injections, Corticosteroid Injections, Platelet Rich Plasma Injections), By Joint type (Knee, Shoulder & Elbow, Ankle & Hip), By End-use (Hospitals, Clinics) & Global Forecast, 2023-2032
A PHP Error was encountered
SeverityWarning
Message getimagesize(https//cdn.gminsights.com/image/rd/healthcare-and-medical-devices/global-joint-pain-injuction-market-size-by-injuction-type-2023-2032.webp)failed to open streamHTTP request failed! HTTP/1.1 520
Filenamev2_reports/body1.php
Line Number435
Backtrace
File/home/admin/web/gminsights.com/public_html/application/views/v2_reports/body1.php
Line435
Functiongetimagesize
File/home/admin/web/gminsights.com/public_html/application/views/v2_layouts/master_header_footer.php
Line1196
Functionview
File/home/admin/web/gminsights.com/public_html/application/controllers/Reports.php
Line701
Functionview
File/home/admin/web/gminsights.com/public_html/index.php
Line305
Functionrequire_once
Joint Pain Injections Market Size
Joint Pain Injections Market size surpassed USD 3.74 billion in 2022 and is estimated to witness 8.7% CAGR between 2023 and 2032. This significant market growth is majorly pertaining to several factors including the Rising prevalence of arthritis and key players in the market are focusing on developing innovative products to meet customers demand and increase their market share.
As we age, our joints tend to suffer more, especially if we have any underlying health conditions. Conditions like arthritis and sacroiliac joint pain can make our joints ache and swell. To ease this discomfort, doctors often inject medications directly into the joint to reduce the swelling and pain. The number of older people is growing, and so is the problem of obesity. This means that more and more people are looking for ways to treat joint pain. To meet this need, a new treatment called platelet-rich plasma (PRP) has been developed. PRP is made from your own blood and injected into the painful joint to relieve pain and stiffness caused by arthritis. These advanced treatment options offer new opportunities for investment, which will likely lead to even more advancements in joint pain care.
High cost of joint pain injections is restraining the market growth. Therefore, the prevalence of musculoskeletal disorders will catalyze the growth of the market. The increase in demand for effective treatment increases the demand for products. However, the market growth is hindered by the high price of joint injections. Additionally, strict product approval regulations are hindering the overall market demand.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Joint Pain Injections Market Size in 2022 | USD 3.74 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 8.7% |
| 2032 Value Projection | USD 9.5 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 180 |
| Tables, Charts & Figures | 197 |
| Segments covered | Injection Type, Joint Type, End-use, and Region. |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
Therapeutics advantages to relieve joint pain & inflammation will drive the market growth
Joint pain is on the rise both in developed and developing countries, leading to a surge in the demand for joint pain injections. These injections have become increasingly sophisticated, allowing doctors to pinpoint the exact source of your pain and provide fast relief. One type of injection, called a facet joint injection, uses a small dose of numbing medicine to target specific areas around the joint. This can alleviate pain by relaxing nearby muscles, ligaments, and tissues. The growing preference for non-surgical treatments is another major driver for the popularity of joint injections. They offer a safe and effective way to manage pain without the need for invasive surgery. As a result, we're seeing a rise in the use of facet joint injections, which are expected to continue throughout the coming years, helping alleviate the burden of joint pain for countless individuals.
Joint Pain Injections Market Analysis
When it comes to joint pain injections, there are three main typesHyaluronic acid injectionsThese injections mimic the natural fluid that cushions your joints, reducing stiffness and discomfort. They're often used for osteoarthritis and other conditions that cause joint wear and tear. Corticosteroid injections These injections help reduce inflammation and pain. They're commonly used for conditions like rheumatoid arthritis and gout. Platelet-rich plasma injections These injections use your own blood to help heal injured joints. Hyaluronic acid injections have been the most popular type in recent years. That's because they can provide long-lasting relief for many people. Plus, they're safe and have few side effects. Corticosteroid injections can also be effective, but they're typically used for short-term relief. Platelet-rich plasma injections are still being studied, but they show promise for treating certain types of joint pain. Overall, the demand for joint pain injections is expected to keep growing. That's because more and more people are suffering from joint pain due to aging, obesity, and other factors.
Based on joint type, the joint pain injections market is segmented as knee, shoulder & elbow, and ankle & hip. The knee segment held a dominated the market in 2022, whereas the hip joint segment is expected to grow with a highest CAGR, owing to the rise in the number of accidents and injuries related to the accidents leading to the hip joint pain and rise in the number of geriatric patients.
Based on end-use the Joint Pain Injections market is segmented as hospitals, clinics, and others. The hospitals segment is estimated to show a lucrative CAGR of over 8.9% through 2032. This high segmental share is attributed to availability of wide varieties of injections in the hospitals or in hospitals pharmacies. Strong end-uses and extensive network of suppliers to hospitals assists to reach a wide customer base and manage consumer compliance. Segment expansion is due to huge need for hospitalization by people with orthopedic diseases.
U.S. Joint Pain Injections Market is anticipated to reach more than USD 4 billion by 2032. The significant market share is owing to several factors including presence of major market players, and the high prevalence of musculoskeletal problems that cause joint aches. Public awareness of non-invasive orthopaedic therapies has grown, as has implant technology innovation and sophisticated healthcare facilities.
According to the Centres for Disease Control and Prevention, chronic pain caused by arthritis affects millions of people in the United States each year. Arthritis affects one out of every four people, and 15 million people report significant joint pain because of it. One of the factors driving the regional market statistics. Furthermore, major market competitors are heavily investing in research, which will benefit the North American industry.
Joint Pain Injections Market Share
Some of the major market players operating in the joint pain injection industry is
- The Zimmer Biomet
- Anika Therapeutics, Inc.
- Bioventus
- Sanofi
- Pacira Biosciences (Flexion)
- OrthogenRx
- Pfizer
- Ferring B.V.
- Lifecore Biomedical
- Wright Medical Group (Stryker)
- Emcyte Corporation
- Stryker
Market players are focusing on the introduction of Visco supplements.
Moreover, increasing awareness of joint pain injections is catalyzing market growth across the region. Rapid adoption of technologically advanced pain management solutions will significantly contribute to the market demand. increasing R&D initiatives by the key market players and advances such as single injection therapy and plasma matrix therapy, will provide lucrative opportunities for the market players to invest and lead to the market growth.
Recent industry developments
- In March 2023, Green Roads, a subsidiary of the Valens Company, made a USD 120,000 donation to the Arthritis Foundation in support of the organization's pain management initiative to advance the improved quality of life for those who live with chronic pain. This donation made Green Roads an official supporting sponsor of the Arthritis Foundation.
- In January 2023, AbbVie received the United States Food and Drug Administration (FDA) approval for SKYRIZI (risankizumab-rzaa) for the treatment of adults with active psoriatic arthritis (PsA), which can be administered with a single injection four times a year.
Impact of COVID-19 pandemic
In the wake of the COVID-19 pandemic, the world faced a major health crisis that left its mark on businesses everywhere. Hospitals and other sectors of the economy were hit hard, and the industry that provides injections for joint pain was no exception. At the start of the pandemic, supply chains were disrupted, making it difficult to get these injections to those who needed them. As a result, many doctors and companies that sell these injections saw their profits shrink. This was because fewer people were going to the hospital, and even when they did, they were often being treated for other, more urgent conditions. But as the pandemic wore on, something unexpected happened. People became more aware of the importance of taking care of their health, and there were advances in the technology used to treat joint pain. This led to an increase in demand for joint pain injections, which has continued to grow even as the pandemic has eased.
Joint Pain Injections Market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments
Click here to Buy Section of this Report
By injection type
- Hyaluronic acid injections
- Corticosteroid injections
- Platelet rich plasma injections
By joint type
- Knee
- Shoulder & elbow
- Ankle & hip
- Others
By end use
- Hospitals
- Clinics
- Others
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy